2012 -- S 3045 SUBSTITUTE A

=======

LC02780/SUB A

=======

STATE OF RHODE ISLAND

IN GENERAL ASSEMBLY

JANUARY SESSION, A.D. 2012

____________

S E N A T E R E S O L U T I O N

CREATING A SPECIAL LEGISLATIVE COMMISSION TO STUDY PATIENT ACCESS TO

MEDICALLY NECESSARY MENTAL HEALTH PRESCRIPTION DRUGS

     

     

     Introduced By: Senators Felag, McCaffrey, Ruggerio, Gallo, and Walaska

     Date Introduced: June 05, 2012

     Referred To: Senate Health & Human Services

1-1

     RESOLVED, That a special legislative commission be and the same is hereby created

1-2

consisting of seven (7) members: three (3) of whom shall be members of the Senate, not more

1-3

than two (2) of whom shall be from the same political party, to be appointed by the President of

1-4

the Senate; one of whom shall be a representative of the Rhode Island Council of Community

1-5

Mental Health Organizations, to be appointed by the President of the Senate; one of whom shall

1-6

be a representative of the Rhode Island Medical Society, to be appointed by the President of the

1-7

Senate; one of whom shall be a pharmacist licensed to practice in the State of Rhode Island, to be

1-8

appointed by the President of the Senate; and one of whom shall be a representative of the health

1-9

insurance industry, to be appointed by the President of the Senate.

1-10

     In lieu of any appointment of a member of the legislature to a permanent advisory

1-11

commission, a legislative study commission, or any commission created by a General Assembly

1-12

resolution, the appointing authority may appoint a member of the general public to serve in lieu

1-13

of a legislator, provided that the majority leader or the minority leader of the political party which

1-14

is entitled to the appointment consents to the member of the general public.

1-15

     The purpose of said commission shall be to make a comprehensive study and develop

1-16

recommendations regarding current Rhode Island law relating to health insurer drug formulary

1-17

exception criteria and the process by which a health insurer is required to cover a non-formulary

1-18

medication deemed medically necessary by a physician or other person authorized to prescribe

1-19

medication.  The commission study shall include, but not be limited to, consideration of requiring

1-20

health insurers to provide coverage for a non-formulary medication, regardless of whether said

2-1

medication meets the nonprofit medical service corporation's medical exception criteria, if the

2-2

medication has been prescribed as treatment for a mental disorder, including schizophrenia, as

2-3

defined by the most recent edition of the Diagnostic and Statistical Manual of Mental Disorders

2-4

(DSM) published by the American Psychiatric Association.

2-5

     Forthwith upon passage of this resolution, the members of the commission shall meet at

2-6

the call of the President of the Senate and organize and shall select a chairperson from amongst

2-7

the legislators. 

2-8

     Vacancies in said commission shall be filled in like manner as the original appointment.

2-9

     The membership of said commission shall receive no compensation for their services.

2-10

     All departments and agencies of the state shall furnish such advice and information,

2-11

documentary and otherwise, to said commission and its agents as is deemed necessary or

2-12

desirable by the commission to facilitate the purposes of this resolution.

2-13

     The Joint Committee on Legislative Services is hereby authorized and directed to provide

2-14

suitable quarters for said commission; and be it further

2-15

     RESOLVED, That the commission shall report its findings and recommendations to the

2-16

Senate no later than March 5, 2013, and said commission shall expire on May 31, 2013.

     

=======

LC02780/SUB A

========

EXPLANATION

BY THE LEGISLATIVE COUNCIL

OF

S E N A T E R E S O L U T I O N

CREATING A SPECIAL LEGISLATIVE COMMISSION TO STUDY PATIENT ACCESS TO

MEDICALLY NECESSARY MENTAL HEALTH PRESCRIPTION DRUGS

***

3-1

     This act resolution would create a seven (7) member special legislative study commission

3-2

whose purpose it would be to study patient access to medically necessary mental health

3-3

prescription drugs, and who would report back to the Senate no later than March 5, 2013, and

3-4

whose life would expire on May 31, 2013.

     

=======

LC02780/SUB A

=======

S3045A